Lv6
2720 积分 2022-02-10 加入
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
5天前
已完结
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
5天前
已完结
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
18天前
已完结
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
18天前
已完结
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
18天前
已完结
皖公网安备34019202002308
